<DOC>
	<DOCNO>NCT00443417</DOCNO>
	<brief_summary>The purpose study find optimistic dose evaluate efficacy safety SK-PC-B70M patient mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>A Trial SK-PC-B70M Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Age range : 50 ~ 85 year Clinical diagnosis probable Alzheimer 's disease ( DSMIV NINCDSADRDA criterion ) MRI within last 12 month consistent diagnosis AD MMSE score 10 26 AChEI memantine discontinue least 3 month prior screen Patient mild cognitive impairment ( MCI ; CDRSB &lt; 2.5 ) Other central nervous disease hypothyroidism , Vitamin B12/ Folic acid deficiency , hypercalcemia , neurosyphilis , AIDS T.I.A Major infarction within last 12 month Any serious disorder could limit ability patient participate study COPD asthma Any condition would make patient caregiver , opinion investigator , unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>